FDA Approved: MULPLETA — Original Application (Eddingpharm (U. S. ) Inc.)

View source ↗

Summary

The FDA granted original approval for Mulpleta (lusutrombopag) for adults with chronic liver disease to raise platelet counts in advance of a scheduled procedur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• MULPLETA (lusutrombopag)

Snippet

ORIG AP for MULPLETA (LUSUTROMBOPAG)